On November 15th, the 20th Award Ceremony & High-end Forum of Golden Bull Awards for China’s Listed Companies, hosted by China Securities Journal, was grandly held in Chengdu, Sichuan Province. Huadong Medicine Co., Ltd. (Huadong Medicine), a member of China Grand Enterprises, Inc. (CGE), won the 2017 Golden Bull Awards for China’s Listed Companies with Most Investment Value. Huadong Medicine also won the 2017 Golden Bull Awards for Investor Relations Management.

It has achieved an average annual growth rate of 25% in net profits in the past five years. In the first three quarters of 2018, it made an operating income of 23.204 billion yuan, a year-on-year increase of 8.17%, and a net profit of 1.809 billion yuan for the shareholders of the listed company, an increase of 21.48%. Continuous and steady growth, strong profitability and growth capability enable Huadong Medicine to win the Golden Bull Awards for Most Investment Value. The winning of the Golden Bull Awards for Investor Relations Management by Huadong Medicine also represents the recognition of investors, Chinese capital markets and mainstream media for their outstanding investor relations management. Since the beginning of 2018, Huadong Medicine has organized many on-site and telephone sessions for strategy exchanges targeting investors, achieving effective communication results and ensuring the rights of investors to keep updated through innovative information communication channels. Huadong Medicine has in recent years adopted a globalization approach to its global ambitions, pressing forward with innovative global strategies, manufacturing leading and competitive products, and striving to achieve the new goal of “double tens of billions”.

Golden Bull Awards for China’s Listed Companies: Created 20 years ago, the Golden Bull Awards are among the most credible and the most authoritative awards in China’s capital market. It has always adhered to a set of selection criteria that are objective, scientific, and fair and attracted great attention from listed companies, research institutions and investors in China and beyond.